Showing results (91-100 of 451) with videos related to
Sort By:
Pageof 46
Clinical and Experimental Rheumatology|April 9, 2016
N-terminal pro Brain Natriuretic Peptide as predictor of outcome in scleroderma renal crisisCecilia Beatrice Chighizola, Francesca Pregnolato, Pier Luigi Meroni, et al.Nature Clinical Practice. Rheumatology|August 26, 2006
Mechanisms and consequences of fibrosis in systemic sclerosisChristopher P Denton, Carol M Black, David J AbrahamArthritis Research & Therapy|June 26, 2013
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cellsAdrian J Gilbane, Christopher P Denton, Alan M HolmesNature Reviews. Rheumatology|August 17, 2018
Major lung complications of systemic sclerosisChristopher P Denton, Athol U Wells, John G CoghlanNature Reviews. Rheumatology|October 15, 2018
Author Correction: Major lung complications of systemic sclerosisChristopher P Denton, Athol U Wells, John G CoghlanAnnals of the New York Academy of Sciences|October 4, 2007
Treatment of autoimmune disease with rabbit anti-T lymphocyte globulin: clinical efficacy and potential mechanisms of actionSimon D Lytton, Christopher P Denton, Achim M NutzenbergerCurrent Opinion in Rheumatology|September 5, 2009
Animal models of scleroderma: lessons from transgenic and knockout miceEmma C Derrett-Smith, Christopher P Denton, Sonali SonnylalRheumatic Diseases Clinics of North America|April 7, 2023
The Exciting Future for Scleroderma: What Therapeutic Pathways Are on the Horizon?Jörg H W Distler, Gabriela Riemekasten, Christopher P DentonThe Journal of Rheumatology|February 5, 2013
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosisAngelo De Lauretis, Piersante Sestini, Panagiotis Pantelidis, et al.Seminars in Respiratory and Critical Care Medicine|May 29, 2019
Multidisciplinary Evaluation in Patients with Lung Disease Associated with Connective Tissue DiseaseAthol Wells, Anand Devaraj, Elizabetta A Renzoni, et al.Pageof 46